Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
- Published In:
- The New England journal of medicine, 393(24), 2409-2420 (2025)
- Authors:
- Nicholls, Stephen J, Pavo, Imre(3), Bhatt, Deepak L, Buse, John B, Del Prato, Stefano, Kahn, Steven E, Lincoff, A Michael, McGuire, Darren K, Miller, Debra, Nauck, Michael A, Nishiyama, Hiroshi, Nissen, Steven E, Sattar, Naveed, Weerakkody, Govinda, Wiese, Russell J, Zinman, Bernard, Zoungas, Sophia, Basile, Jan, Davies, Melanie J, Giorgino, Francesco, Kellerer, Monika, Ji, Linong, Varkonyi, Tamas, Menon, Venu, Broder, Jonathan C, Herschtal, Alan, D'Alessio, David
- Database ID:
- RPEP-12781
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12781APA
Nicholls, Stephen J; Pavo, Imre; Bhatt, Deepak L; Buse, John B; Del Prato, Stefano; Kahn, Steven E; Lincoff, A Michael; McGuire, Darren K; Miller, Debra; Nauck, Michael A; Nishiyama, Hiroshi; Nissen, Steven E; Sattar, Naveed; Weerakkody, Govinda; Wiese, Russell J; Zinman, Bernard; Zoungas, Sophia; Basile, Jan; Davies, Melanie J; Giorgino, Francesco; Kellerer, Monika; Ji, Linong; Varkonyi, Tamas; Menon, Venu; Broder, Jonathan C; Herschtal, Alan; D'Alessio, David. (2025). Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.. The New England journal of medicine, 393(24), 2409-2420. https://doi.org/10.1056/NEJMoa2505928
MLA
Nicholls, Stephen J, et al. "Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.." The New England journal of medicine, 2025. https://doi.org/10.1056/NEJMoa2505928
RethinkPeptides
RethinkPeptides Research Database. "Cardiovascular Outcomes with Tirzepatide versus Dulaglutide ..." RPEP-12781. Retrieved from https://rethinkpeptides.com/research/nicholls-2025-cardiovascular-outcomes-with-tirzepatide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.